Vaultly tag

Biotechnology news and market signals

Public Vaultly articles where Biotechnology appears among the affected assets. Premium market intelligence becomes searchable here after 24 hours.

Orakl Oncology Secures $34 Million for Virtual Cancer Drug Trials

StartupsFree

Medium 7/10Biotechnology Pharmaceuticals

Orakl Oncology Secures $34 Million for Virtual Cancer Drug Trials

Orakl Oncology has successfully raised $34 million in a new funding round. The company plans to utilize these funds to advance its innovative approach to testing cancer drugs using 'virtual patients'.

November 12, 2026